The Father of Autoimmunity: A Profile of Noel Rose

By revealing that animals could develop immune responses against their own tissues, the physician-scientist established an entirely new field of science.

Written byDiana Kwon
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

ABOVE: Courtesy of Noel Rose and JHU

Science is full of ideas that have been proven wrong. Up until the 1950s, one prevailing view among scientists was that the body could not produce antibodies against itself. This concept, known as horror autotoxicus, or the fear of self-toxicity, was coined in the 19th century by Paul Ehrlich, a German physician-scientist who was awarded a Nobel Prize for his contributions to immunology.

Nearly half a century later, horror autotoxicus was overturned by Ernest Witebsky, a protégé of one of Ehrlich’s trainees, with the help of Witebsky’s student, Noel Rose.

When Rose joined Witebsky’s lab at the University at Buffalo in 1951, Witebsky was studying organ-specific antigens—molecules that make different cell types functionally distinct. Witebsky was particularly interested in thyroglobulin, a large protein found exclusively in cells of the thyroid gland, and he gave Rose the task of identifying the properties that made ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile

Published In

June 2020

An Infant's Bounty

Babies amass microbes that can pave the way to a healthy life

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies